Get the latest tech news

Novo Nordisk, Eli Lilly Report GLP-1 Signals of Slowed Biological Aging at ARDD

Novo Nordisk and Eli Lilly presented early data at the ARDD conference suggesting semaglutide and tirzepatide may slow molecular...

None

Related news:

Eli Lilly CEO Dave Ricks says 700,000 new seniors have started GLP-1s after Medicare coverage, and 70% are on Lilly drugs

Novo Nordisk Will Use Anthropic’s Claude for Drug Research

Novo Nordisk (NVO) Taps Anthropic AI to Develop Next-Generation Medicines